Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS)
International Journal of Clinical Practice Sep 02, 2017
Hassanein M, et al. – In this Canagliflozin in Ramadan Tolerance Observational Study (CRATOS), the tolerability of canagliflozin was compared with sulphonylureas in patients with type 2 diabetes mellitus (T2DM) who fast during Ramadan. Outcomes supported the use of canagliflozin for the treatment of adults with T2DM who fast during Ramadan.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries